This report examines AI's potential in drug discovery, exploring key applications, assessing maturity, identifying barriers, and proposing solutions. It emphasizes the crucial role of health research funders in shaping this dynamic field to address urgent health needs equitably.
Education
- MBA, Harvard Business School
- BA, government, summa cum laude and Phi Beta Kappa, Dartmouth College
Andrew Rodriguez is a core member of the Health Care, Strategy, and Corporate Development practices at Boston Consulting Group.
Since joining BCG in 2002, Andrew has acquired broad health care experience in multiple sectors, focusing on biopharmaceuticals, vaccines, and global health. His clients have included multinational companies, foundations, and international organizations. As a core member of the firm’s global-health team, he has worked extensively on a range of assignments with the Bill & Melinda Gates Foundation.
Before joining BCG, Andrew was a strategic-planning manager with the worldwide beverage-company Diageo and cofounder of the business accelerator Techwell.
